Silver Nanoparticles: Biosynthesis Using an ATCC Reference Strain of Pseudomonas aeruginosa and Activity as Broad Spectrum Clinical Antibacterial Agents

International Journal of Biomaterials

Volumn 2016, Issue , 2016, Pages

  Quinteros, Melisa A ^a   Aiassa Martínez, Ivana M ^a   Dalmasso, Pablo R ^b   Páez, Paulina L ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSIDAD NACIONAL DE SANTIAGO DEL ESTERO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDE; CIPROFLOXACIN; SILVER NANOPARTICLE; SILVER NITRATE;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BIOSYNTHESIS; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOTOXICITY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GROWTH INHIBITION; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION;

EID: 84975230892     PISSN: 16878787     EISSN: 16878795     Source Type: Journal    
DOI: 10.1155/2016/5971047     Document Type: Article

References (16)

1. B. Spellberg, R. Guidos, D. Gilbert et al., "The epidemic of antibiotic-resistant infections: a call to action for the medical community from the infectious diseases society of America," Clinical Infectious Diseases, vol. 46, no. 2, pp. 155-164, 2008.
2. D. J. Diekema, K. J. Dodgson, B. Sigurdardottir, and M. A. Pfaller, "Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need," Journal of Clinical Microbiology, vol. 42, no. 7, pp. 2879-2883, 2004.
3. A. R. M. Coates and Y. Hu, "Novel approaches to developing new antibiotics for bacterial infections," British Journal of Pharmacology, vol. 152, no. 8, pp. 1147-1154, 2007.
4. M. J. Hajipour, K. M. Fromm, A. Akbar Ashkarran et al., "Antibacterial properties of nanoparticles," Trends in Biotechnology, vol. 30, no. 10, pp. 499-511, 2012.
5. M.-A. Neouze, "Nanoparticle assemblies: main synthesis pathways and brief overview on some important applications," Journal of Materials Science, vol. 48, no. 21, pp. 7321-7349, 2013.
6. L. Zhang, F. X. Gu, J. M. Chan, A. Z. Wang, R. S. Langer, and O. C. Farokhzad, "Nanoparticles in medicine: therapeutic applications and developments," Clinical Pharmacology and Therapeutics, vol. 83, no. 5, pp. 761-769, 2008.
7. H. M. C. De Azeredo, "Antimicrobial nanostructures in food packaging," Trends in Food Science and Technology, vol. 30, no. 1, pp. 56-69, 2013.
8. M. Rai, A. Yadav, and A. Gade, "Silver nanoparticles as a new generation of antimicrobials," Biotechnology Advances, vol. 27, no. 1, pp. 76-83, 2009.
9. S. Eckhardt, P. S. Brunetto, J. Gagnon, M. Priebe, B. Giese, and K. M. Fromm, "Nanobio silver: its interactions with peptides and bacteria, and its uses in medicine," Chemical Reviews, vol. 113, no. 7, pp. 4708-4754, 2013.
10. K.N. Thakkar, S. S. Mhatre, and R. Y. Parikh, "Biological synthesis of metallic nanoparticles," Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 6, no. 2, pp. 257-262, 2010.
11. N. I. Hulkoti and T. C. Taranath, "Biosynthesis of nanoparticles using microbes-a review," Colloids and Surfaces B: Biointerfaces, vol. 121, pp. 474-483, 2014.
12. C. G. Kumar and S. K. Mamidyala, "Extracellular synthesis of silver nanoparticles using culture supernatant of Pseudomonas aeruginosa," Colloids and Surfaces B: Biointerfaces, vol. 84, no. 2, pp. 462-466, 2011.
13. P. Mulvaney, "Surface plasmon spectroscopy of nanosized metal particles," Langmuir, vol. 12, no. 3, pp. 788-800, 1996.
14. N. Basavegowda and Y. Rok Lee, "Synthesis of silver nanoparticles using Satsuma mandarin (Citrus unshiu) peel extract: a novel approach towardswaste utilization," Materials Letters, vol. 109, pp. 31-33, 2013.
15. K. Kalishwaralal, S. Barath Mani Kanth, S. R. K. Pandian, V. Deepak, and S. Gurunathan, "Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis," Colloids and Surfaces B: Biointerfaces, vol. 79, no. 2, pp. 340-344, 2010.
16. A. L. Cohen, D. Calfee, S. K. Fridkin et al., "Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC position paper," Infection Control and Hospital Epidemiology, vol. 29, no. 10, pp. 901-913, 2008.